Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. / Jakobsen, P H; Morris-Jones, S; Rønn, A; Hviid, L; Theander, T G; Elhassan, I M; Bygbjerg, I C; Greenwood, B M.

In: Immunology, Vol. 83, No. 4, 1994, p. 665-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jakobsen, PH, Morris-Jones, S, Rønn, A, Hviid, L, Theander, TG, Elhassan, IM, Bygbjerg, IC & Greenwood, BM 1994, 'Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity', Immunology, vol. 83, no. 4, pp. 665-9.

APA

Jakobsen, P. H., Morris-Jones, S., Rønn, A., Hviid, L., Theander, T. G., Elhassan, I. M., Bygbjerg, I. C., & Greenwood, B. M. (1994). Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology, 83(4), 665-9.

Vancouver

Jakobsen PH, Morris-Jones S, Rønn A, Hviid L, Theander TG, Elhassan IM et al. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology. 1994;83(4):665-9.

Author

Jakobsen, P H ; Morris-Jones, S ; Rønn, A ; Hviid, L ; Theander, T G ; Elhassan, I M ; Bygbjerg, I C ; Greenwood, B M. / Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. In: Immunology. 1994 ; Vol. 83, No. 4. pp. 665-9.

Bibtex

@article{a9dca7c0a06e11dd86a6000ea68e967b,
title = "Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity",
abstract = "Increased serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), soluble endothelial leucocyte adhesion molecule-1 (sELAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were detected in Danish malaria patients infected with sequestering Plasmodium falciparum or non-sequestering P. vivax parasites, as well as in patients with sepsis or meningitis. Levels of soluble adhesion molecules remained elevated in the P. falciparum patients for several weeks after initiation of treatment. Plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 were higher in Gambian children with severe P. falciparum malaria than in children with mild malaria. Plasma levels of sVCAM-1 and sELAM-1 were significantly correlated. Plasma levels of sELAM-1 and sVCAM-1 may reflect endothelial inflammatory reactions and these reactions may be harmful for humans infected with malaria parasites.",
author = "Jakobsen, {P H} and S Morris-Jones and A R{\o}nn and L Hviid and Theander, {T G} and Elhassan, {I M} and Bygbjerg, {I C} and Greenwood, {B M}",
note = "Keywords: Adolescent; Adult; Aged; Biological Markers; Cell Adhesion Molecules; Child; E-Selectin; Humans; Intercellular Adhesion Molecule-1; Malaria, Falciparum; Malaria, Vivax; Meningitis, Meningococcal; Middle Aged; Parasitemia; Solubility; Vascular Cell Adhesion Molecule-1",
year = "1994",
language = "English",
volume = "83",
pages = "665--9",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity

AU - Jakobsen, P H

AU - Morris-Jones, S

AU - Rønn, A

AU - Hviid, L

AU - Theander, T G

AU - Elhassan, I M

AU - Bygbjerg, I C

AU - Greenwood, B M

N1 - Keywords: Adolescent; Adult; Aged; Biological Markers; Cell Adhesion Molecules; Child; E-Selectin; Humans; Intercellular Adhesion Molecule-1; Malaria, Falciparum; Malaria, Vivax; Meningitis, Meningococcal; Middle Aged; Parasitemia; Solubility; Vascular Cell Adhesion Molecule-1

PY - 1994

Y1 - 1994

N2 - Increased serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), soluble endothelial leucocyte adhesion molecule-1 (sELAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were detected in Danish malaria patients infected with sequestering Plasmodium falciparum or non-sequestering P. vivax parasites, as well as in patients with sepsis or meningitis. Levels of soluble adhesion molecules remained elevated in the P. falciparum patients for several weeks after initiation of treatment. Plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 were higher in Gambian children with severe P. falciparum malaria than in children with mild malaria. Plasma levels of sVCAM-1 and sELAM-1 were significantly correlated. Plasma levels of sELAM-1 and sVCAM-1 may reflect endothelial inflammatory reactions and these reactions may be harmful for humans infected with malaria parasites.

AB - Increased serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), soluble endothelial leucocyte adhesion molecule-1 (sELAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were detected in Danish malaria patients infected with sequestering Plasmodium falciparum or non-sequestering P. vivax parasites, as well as in patients with sepsis or meningitis. Levels of soluble adhesion molecules remained elevated in the P. falciparum patients for several weeks after initiation of treatment. Plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 were higher in Gambian children with severe P. falciparum malaria than in children with mild malaria. Plasma levels of sVCAM-1 and sELAM-1 were significantly correlated. Plasma levels of sELAM-1 and sVCAM-1 may reflect endothelial inflammatory reactions and these reactions may be harmful for humans infected with malaria parasites.

M3 - Journal article

C2 - 7533138

VL - 83

SP - 665

EP - 669

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 4

ER -

ID: 6748291